Compounds > tyrosine

tyrosine and Cholangiocarcinoma

tyrosine has been researched along with Cholangiocarcinoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's3 (37.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Alva-Ruiz, R; Borad, M; Buckarma, EH; Buijsman, RC; Conboy, CB; de Man, J; Gores, GJ; Graham, RP; Guo, Y; Ilyas, SI; Jessen, E; McCabe, CE; Mun, DG; O'Brien, D; Pandey, A; Smoot, RL; Tomlinson, JL; Truty, MJ; Vu, D; Wang, J; Watkins, RD; Werneburg, NW; Yonkus, JA1
Chang, HW; Chang, VHS; Chien, LN; Chu, PG; Dong, F; Jia, W; Lin, IH; Liu, YR; Wu, MJ; Xie, G; Yang, YSH; Yen, Y1
Anzai, N; Dokduang, H; Endou, H; Hayashi, K; Jutabha, P; Loilome, W; Namwat, N; Sangkhamanon, S; Yongvanit, P; Yothaisong, S1
Gores, GJ; Hernandez, MC; Hirsova, P; Kabashima, A; Smoot, RL; Sosa, C; Sugihara, T; Truty, MJ; Vasmatzis, G; Werneburg, NW; Yang, L; Yohanathan, L1
Blechacz, BR; Bronk, SF; Gores, GJ; Sirica, AE; Smoot, RL; Werneburg, NW1
Gui, A; Kitazawa, M; Kobayashi, A; Miyagawa, S; Motoyama, H; Takeoka, M1
DePinho, RA; Farazi, PA; Glickman, J; Kalluri, R; Zeisberg, M; Zhang, Y1
Bronk, SF; Gores, GJ; Haan, S; Isomoto, H; Kobayashi, S; Mott, JL; Werneburg, NW1

Other Studies

8 other study(ies) available for tyrosine and Cholangiocarcinoma

ArticleYear
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.
    Journal of hepatology, 2023, Volume: 78, Issue:1

    Topics: Adaptor Proteins, Signal Transducing; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Gene Expression Regulation, Neoplastic; Humans; Phosphoproteins; Transcription Factors; Tyrosine; YAP-Signaling Proteins

2023
Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats.
    Scientific reports, 2020, 01-21, Volume: 10, Issue:1

    Topics: Administration, Oral; alpha-Tocopherol; Animals; Bile Duct Neoplasms; Bile Ducts; Cell Transformation, Neoplastic; Cholangiocarcinoma; Cholestasis; Feces; Gastrointestinal Microbiome; Gene Expression Regulation; Humans; Omeprazole; Proton Pump Inhibitors; Rats, Wistar; Retinoid X Receptor alpha; RNA-Binding Proteins; RNA, Ribosomal, 16S; Tyrosine

2020
Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2017, Volume: 39, Issue:3

    Topics: Animals; Apoptosis; Benzoxazoles; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Mice; Molecular Targeted Therapy; Tyrosine; Xenograft Model Antitumor Assays

2017
YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity.
    Molecular cancer research : MCR, 2018, Volume: 16, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cholangiocarcinoma; Cytoplasm; Dasatinib; Gene Expression Regulation, Neoplastic; Humans; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mice; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; src-Family Kinases; Transcription Factors; Tyrosine; Xenograft Model Antitumor Assays; YAP-Signaling Proteins

2018
Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.
    Hepatology (Baltimore, Md.), 2009, Volume: 50, Issue:6

    Topics: Animals; Apoptosis; Benzenesulfonates; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Enzyme Activation; Humans; Male; Niacinamide; Phenylurea Compounds; Phosphorylation; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyridines; Rats; Rats, Inbred F344; Signal Transduction; Sorafenib; STAT3 Transcription Factor; Tyrosine

2009
Impaired degradation followed by enhanced recycling of epidermal growth factor receptor caused by hypo-phosphorylation of tyrosine 1045 in RBE cells.
    BMC cancer, 2012, May-16, Volume: 12

    Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; Endosomes; Epidermal Growth Factor; ErbB Receptors; Humans; Phosphorylation; Protein Binding; Protein Transport; Proteolysis; Proto-Oncogene Proteins c-cbl; Signal Transduction; Tyrosine; Ubiquitination

2012
Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Cancer research, 2006, Jul-01, Volume: 66, Issue:13

    Topics: Animals; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cadherins; Carbon Tetrachloride Poisoning; Cholangiocarcinoma; Cyclooxygenase 2; Extracellular Matrix; Female; Fibrosis; Germ-Line Mutation; Hyperplasia; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Proto-Oncogene Proteins c-met; Receptor, ErbB-2; Tumor Suppressor Protein p53; Tyrosine

2006
Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing.
    Gastroenterology, 2007, Volume: 132, Issue:1

    Topics: Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cholangiocarcinoma; CpG Islands; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Interleukin-6; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; TNF-Related Apoptosis-Inducing Ligand; Tyrosine

2007